Seaport Therapeutics, Inc. (SPTX)

Seaport Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	May 22, 2026	Dec 31, 2025	Dec 31, 2024
Market Capitalization	928	-	-
Enterprise Value	717	-	-
Debt / Equity Ratio	0.02	0.02	0.02
Net Debt / Equity Ratio	-0.91	-0.91	-1.01
Net Debt / EBITDA Ratio	2.48	2.48	5.82
Net Debt / FCF Ratio	2.69	2.69	10.22
Quick Ratio	17.13	17.13	27.72
Current Ratio	17.46	17.46	27.82
Return on Equity (ROE)	-28.08%	-28.08%	-
Return on Assets (ROA)	-18.90%	-18.90%	-
Return on Capital Employed (ROCE)	-36.10%	-36.10%	-17.20%
Buyback Yield / Dilution	-	-151.76%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q